Recently, Cui et al. [61] proved that NF-κB activation enhances the expression of survivin in bladder cancer cell lines and in vivo, leading thereby to enhanced proliferation and apoptosis inhibition. The gene discussed is NFKB1; the disease is urinary bladder cancer.